Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetes.
Kahn
Steven E
SE
Zinman
Bernard
B
D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D015203:Reproducibility of Results; D045162:Thiazolidinediones / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones